Abstract
The in vitro activity of a multilamellar liposomal formulation of nystatin (Nyotran) was compared with those of free nystatin and four pharmaceutical preparations of amphotericin B. MICs for 200 isolates of two Aspergillus spp., seven Candida spp., and Cryptococcus neoformans were determined by a broth microdilution adaptation of the method recommended by the National Committee for Clinical Laboratory Standards. Minimum lethal concentrations (MLCs) of the six antifungal preparations were also determined. Both nystatin formulations possessed fungistatic and fungicidal activities against the 10 species tested. Liposomal nystatin appeared to be as active as free nystatin, with MICs and MLCs that were similar to, or lower than, those of the latter. Neither formulation of nystatin was as active as amphotericin B deoxycholate (Fungizone) or amphotericin B lipid complex (Abelcet), but both were more effective than liposomal amphotericin B (AmBisome). Our results suggest that further evaluation of liposomal nystatin is justified.
MeSH Terms
Amphotericin B/pharmacology
Antifungal Agents/chemistry,pharmacology
Aspergillus/drug effects
Candida/drug effects
Cryptococcus neoformans/drug effects
Drug Carriers
Liposomes
Microbial Sensitivity Tests
Nystatin/chemistry,pharmacology
Chemicals
Antifungal Agents
Drug Carriers
Liposomes
Nystatin
Amphotericin B
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Johnson E M
Mycology Reference Laboratory, Public Health Laboratory Service, Bristol, United Kingdom.
Ojwang J O
Szekely A
Wallace T L
Warnock D W
References (22)
22 references, click to expand
-
Resistance to polyene antibiotics and correlated sterol changes in two isolates of Candida tropicalis from a patient with an amphotericin B-resistant funguria.
J Infect Dis. 1974 Jan;129(1):53-8
PMID: 4587944
-
Nystatin (mycostatin) therapy in experimental coccidioidomycosis.
Am Rev Tuberc. 1955 Jul;72(1):64-70
PMID: 14388209
-
Evaluation of the action of nystatin on Histoplasma capsulatum in vitro and in hamsters and mice.
Antibiot Chemother (Northfield). 1956 Jan;6(1):23-35
PMID: 24543868
-
Fungicidin, an antibiotic produced by a soil actinomycete.
Proc Soc Exp Biol Med. 1951 Jan;76(1):93-7
PMID: 14816400
-
Formulation, toxicity, and antifungal activity in vitro of liposome-encapsulated nystatin as therapeutic agent for systemic candidiasis.
Antimicrob Agents Chemother. 1987 Dec;31(12):1897-900
PMID: 3439798
-
Comparative in vitro effects of liposomal amphotericin B, amphotericin B-deoxycholate, and free amphotericin B against fungal strains determined by using MIC and minimal lethal concentration susceptibility studies and time-kill curves.
Antimicrob Agents Chemother. 1991 Jan;35(1):188-91
PMID: 2014976
-
Lipid formulations of amphotericin B: recent progress and future directions.
Clin Infect Dis. 1996 May;22 Suppl 2:S133-44
PMID: 8722841
-
Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice.
Antimicrob Agents Chemother. 1995 Sep;39(9):1954-8
PMID: 8540697
-
Comparison of antifungal activity of amphotericin B deoxycholate suspension with that of amphotericin B cholesteryl sulfate colloidal dispersion.
Antimicrob Agents Chemother. 1992 Feb;36(2):486-8
PMID: 1605618
-
In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin B.
Antimicrob Agents Chemother. 1984 Mar;25(3):387-9
PMID: 6372684
-
Some effects of nystatin on the growth of four Aspergillus species.
J Gen Microbiol. 1965 Jul;40(1):107-18
PMID: 5323080
-
Comparison of the activity of free and liposomal amphotericin B in vitro and in a model of systemic and localized murine candidiasis.
J Infect Dis. 1994 May;169(5):1057-61
PMID: 8169391
-
Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B.
Eur J Clin Microbiol Infect Dis. 1991 Aug;10(8):665-8
PMID: 1748123
-
Toxicity and therapeutic effects in mice of liposome-encapsulated nystatin for systemic fungal infections.
Antimicrob Agents Chemother. 1987 Dec;31(12):1901-3
PMID: 3439799
-
Effect of fungicidin (nystatin) in mice injected with lethal mixtures of aureomycin and Candida albicans.
Science. 1953 May 29;117(3048):609-10
PMID: 13056635
-
Antifungal activity of candidin, nystatin, eulicin, and stilbamidine against experimental infections in the mouse.
Antibiot Chemother (Northfield). 1958 Jul;8(7):364-71
PMID: 24544801
-
Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B.
J Infect Dis. 1983 May;147(5):939-45
PMID: 6842027
-
Polyene resistance in ergosterol producing strains of Candida albicans.
Mycoses. 1991 Jan-Feb;34(1-2):75-83
PMID: 1922193
-
Release of amphotericin B from delivery systems and its action against fungal and mammalian cells.
J Drug Target. 1997;4(5):311-9
PMID: 9169988
-
Amphotericin B: 30 years of clinical experience.
Rev Infect Dis. 1990 Mar-Apr;12(2):308-29
PMID: 2184499
-
Treatment of the deep mycoses.
AMA Arch Intern Med. 1958 Apr;101(4):765-802
PMID: 13519921
-
Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice.
Antimicrob Agents Chemother. 1997 Oct;41(10):2238-43
PMID: 9333054